Feng, Yongliang
Chen, Jing
Yao, Tian
Chang, Yue
Li, Xiaoqing
Xing, Rongqin
Li, Hong
Xie, Ruixue
Zhang, Xiaohong
Wei, Zhiyun
Mu, Shengcai
Liu, Ling
Feng, Lizhong
Wang, Suping http://orcid.org/0000-0002-1476-5595
Clinical trials referenced in this document:
Documents that mention this clinical trial
Safety and immunogenicity of inactivated SARS-CoV-2 vaccine in high-risk occupational population: a randomized, parallel, controlled clinical trial
https://doi.org/10.1186/s40249-021-00924-2
Documents that mention this clinical trial
Safety and immunogenicity of inactivated SARS-CoV-2 vaccine in high-risk occupational population: a randomized, parallel, controlled clinical trial
https://doi.org/10.1186/s40249-021-00924-2
Funding for this research was provided by:
the COVID-19 Project of Shanxi Provincial Finance, and the Project of Shanxi Provincial Key Laboratory for major infectious disease response.
Article History
Received: 20 August 2021
Accepted: 15 December 2021
First Online: 22 December 2021
Declarations
:
: The study was approved by the Ethics Committee of Shanxi Provincial Center for Disease Control (SXCDCIRBPJ2020056001) and Prevention and the Chinese Clinical Trial Registry (ChiCTR2100041705, ChiCTR2100041706).
: Not applicable.
: All authors declare that they have no competing interests.